ArticlePsychopharmacology2026
Peripheral inflammation mediates the relationship between early life stress and alcohol use.
Article in Psychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03594435 (A Randomized Controlled Clinical Trial of the Neuroimmune Modulator Ibudilast for the Treatment of Alcohol Use Disorder), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Randomized Controlled Clinical Trial of the Neuroimmune Modulator Ibudilast for the Treatment of Alcohol Use Disorder
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
rationaleEarly life stress (ELS) is associated with an increased risk for alcohol consumption and development of alcohol use disorder (AUD). Inflammation may be a sex-dependent link between ELS and alcohol use; however, there is limited evidence to support such an association in individuals with AUD.
methodsThis secondary analysis utilized cross-sectional mediation to investigate the role of peripheral inflammation in the relationship between ELS and alcohol consumption (i.e., drinks per drinking day (DPDD)) in treatment-seeking individuals with AUD (n = 99; 60 M/39 F). A cross-sectional moderated mediation analysis was conducted to test sex as a moderator in the link between ELS and inflammation for the above relationship. ELS was conceptualized as a dichotomous "no-moderate ELS" vs. "high-ELS" predictor.
resultsHigh-ELS was associated with higher inflammation (95%CI 0.039,1.558), and higher inflammation was associated with greater DPDD (95%CI 0.024,0.098). A mediation effect emerged where high-ELS influenced greater DPDD through elevated inflammation (ab = 0.044, 95%CI 0.002,0.113). No direct effects between ELS and DPDD emerged (95%CI -0.177,0.108). The interaction between ELS and sex on inflammation was significant for females (95%CI: 0.304,2.719) but not males (95%CI: -0.634,1.270). The mediation relationship between ELS and DPDD through inflammation was significant for females (ab(female) = 0.087, 95%CI: 0.013,0.199) but not males (95%CI: -0.040,0.086).
conclusionsFindings suggest that ELS is associated with recent alcohol use through peripheral inflammation in treatment-seeking individuals with AUD and indicate that this pathway is sex-dependent. Inflammation may be a treatment target for individuals with AUD who have experienced ELS, especially females. CLINICAL TRIALS REGISTRATION: NCT03594435, registered July 11, 2018.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.